A Clinical Score for Predicting the Paroxysmal Supraventricular Tachycardia’s Recurrence Risk; a Retrospective Cross-sectional Study
dc.contributor.author | Yuksen C. | |
dc.contributor.author | Tienpratarn W. | |
dc.contributor.author | Promkul R. | |
dc.contributor.author | Jenpanitpong C. | |
dc.contributor.author | Watcharakitpaisan S. | |
dc.contributor.author | Yaithet J. | |
dc.contributor.author | Phonphom V. | |
dc.contributor.correspondence | Yuksen C. | |
dc.contributor.other | Mahidol University | |
dc.date.accessioned | 2024-11-15T18:55:31Z | |
dc.date.available | 2024-11-15T18:55:31Z | |
dc.date.issued | 2023-01-01 | |
dc.description.abstract | Introduction: Identifying prognostic variables associated with the probability of recurrent paroxysmal supraventricular tachycardia (PSVT) would aid decision-making regarding disposition of the patients. This study aims to develop a clinical scoring system to predict PSVT recurrence after adenosine administration in the emergency department (ED). Methods: This retrospective cross-sectional study was conducted on patients who were referred to the emergency department of Ramathibodi Hospital, a university-affiliated super-tertiary care hospital in Bangkok, Thailand, with diagnosis of PSVT during a 10-year period from 01 January 2010 until 31 December 2020. The cases were divided into recurrent and non-recurrent PSVT based on the response to standard treatment and the independent predictors of recurrence were studied using multivariable logistic regression analysis. Results: 264 patients were diagnosed with PSVT and successfully converted by adenosine. 24 (9.1%) had recurrent PSVT, and 240 (90.9%) had no recurrent PSVT in the same ED visit. The risk of PSVT recurrence in ED corresponded with the history of hypertension (p = 0.059), valvular heart disease (p = 0.052), heart rate ≥100 (p = 0.012), and systolic blood pressure < 100 after electrocardiogram (ECG) converted to sinus rhythm (p = 0.022) and total dose of adenosine (p = 0.002). We developed a clinical prediction score of PSVT recurrence with an accuracy of 79.5%. A score of 0 (low risk), 1–2 (moderate risk), and > 2 (high risk) had a positive likelihood ratio (LR+) of 0.31, 0.56 and 2.33, respectively. Conclusion: It seems that, using the PSVT recurrence score we could screen the high-risk patients for PSVT recurrence (score>2) who need to be observed for at least 6-12 hours and receive cardiologist consultation in ED. In addition, the moderate and low-risk group (score 0-2) need to be observed for 1 hour and can be discharged fromED. | |
dc.identifier.citation | Archives of Academic Emergency Medicine Vol.11 No.1 (2023) | |
dc.identifier.doi | 10.22037/aaem.v11i1.1825 | |
dc.identifier.eissn | 26454904 | |
dc.identifier.scopus | 2-s2.0-85199751934 | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/102027 | |
dc.rights.holder | SCOPUS | |
dc.subject | Medicine | |
dc.title | A Clinical Score for Predicting the Paroxysmal Supraventricular Tachycardia’s Recurrence Risk; a Retrospective Cross-sectional Study | |
dc.type | Article | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85199751934&origin=inward | |
oaire.citation.issue | 1 | |
oaire.citation.title | Archives of Academic Emergency Medicine | |
oaire.citation.volume | 11 | |
oairecerif.author.affiliation | Ramathibodi Hospital | |
oairecerif.author.affiliation | Faculty of Medicine Ramathibodi Hospital, Mahidol University |